Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
07/2004
07/22/2004WO2004060371A1 N-(substituted arylmethyl)-4-(disubstituted methyl) piperidines and pyridines
07/22/2004WO2004060362A2 COMPOSITIONS AND METHODS FOR INHIBITING TGF-β
07/22/2004WO2004060308A2 Thiosemicarbazones as anti-virals and immunopotentiators
07/22/2004WO2004060306A2 Anti-inflammatory medicaments
07/22/2004WO2004060305A2 Anti-cancer medicaments
07/22/2004WO2004014384A3 Cyclic compounds containing zinc binding groups as matrix metalloproteinase inhibitors
07/22/2004WO2003044014A8 Indole-2-carboxamides as factor xa inhibitors
07/22/2004US20040143131 in particular,manufacturing a 5-(tert-butylcarbamoyl)-aminomethyl-oxazolidinone by condensing a carbamate with a tert-butylcarbamoyl protected derivative of glycidylamine or 3-amino-1-halopropanol, intermediates
07/22/2004US20040143115 e.g., 1-[2-Benzoxazol-2-ylaminomethyl)-piperidin-1-yl]-1-(2-methyl-5phenyl-thiazol4-yl)-methanone; used to treat disorders where an antagonist of a human orexin receptor is required
07/22/2004US20040143018 Thrombosis; emphysema; antihistamines; cirrhosis; antiarthritic agents; anticancer agenst
07/22/2004US20040142999 Novel compounds and compositions as cathepsin inhibitors
07/22/2004US20040142997 Alzheimer's disease
07/22/2004US20040142986 Controlling transforming growth facor; artificial skin; wound healing agents
07/22/2004US20040142981 Sterilization, antiseptics for bacteria infections
07/22/2004US20040142980 Viricides; hepatitis virus infections
07/22/2004US20040142978 Aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2
07/22/2004US20040142971 Benzothiophene compounds having antiinfective activity
07/22/2004US20040142948 Cardiovascular disorders; hypotensive agents ; respiratory system disorders; antiinflammatory agents; restenosis ; antiarthritic agents; atherosclerosis; anticholesterol agents; Alzheimer's disease; antidiabetic agents
07/22/2004US20040142939 antimicrobials with activity against human and veterinary pathogens: Gram-positive aerobic bacteria multiply-resistant staphylococci and streptococci, anaerobic organisms bacteroides and clostridia and acid-fast organisms such as Mycobacterium
07/22/2004US20040142933 treatment of schizophrenia and other central nervous system (CNS) disorders
07/22/2004US20040142930 excellent phosphodiesterase V (PDE V) inhibitory activity, and being useful as a remedy for the prophylaxis or treatment of penile erectile dysfunction with few side effects
07/22/2004US20040142924 6-Phenylpyridyl-2-amine derivatives useful as NOS inhibitors
07/22/2004CA2513627A1 Anti-inflammatory medicaments
07/22/2004CA2511873A1 Modulation of protein functionalities
07/22/2004CA2511840A1 Anti-cancer medicaments
07/22/2004CA2511646A1 Thiosemicarbazones as anti-virals and immunopotentiators
07/21/2004EP1439178A1 HETEROCYCLIC COMPOUNDS, OXAZOLE DERIVATIVES, PROCESS FOR PREPARATION OF THE SAME AND USE THEREOF
07/21/2004EP1438352A1 Low color, low sodium benzoxazinone uv absorbers and process for making same
07/21/2004EP1438304A1 Novel substituted 4-phenyl-4- 1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists
07/21/2004EP1438292A1 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
07/21/2004EP1438288A1 Substituted thioacetamides
07/21/2004EP1438053A1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same
07/21/2004EP1438049A2 Substituted 4-phenyl-4-(1h-imidazol-2-yl)-piperidine derivatives for reducing ischaemic damage
07/21/2004EP1100786B1 Antiviral pyrimidinedione derivatives and process for the preparation thereof
07/21/2004EP0757685B1 Novel acyclic and cyclic amides as neurotransmitter release enhancers
07/21/2004CN1514833A Novel tyrosine kinase inhibitors
07/21/2004CN1514829A Novel herbicides
07/21/2004CN1514828A Pyrazole derivatives for treating HIV
07/21/2004CN1513851A Synthesis method of 5-hydroxy methyl furazolidone
07/21/2004CN1513850A Rhodoalkane kind compound, synthesis method and its use
07/21/2004CN1158266C Compounds
07/21/2004CN1158258C Alpha 1 beta-adrenergic receptor antagonists
07/20/2004US6765021 Antidiabetic agents
07/20/2004US6765012 For modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation
07/20/2004US6765009 1,4-Disubstituted benzo-fused compounds
07/20/2004US6765008 Pyrrolopyrimidines as CRF antagonists
07/20/2004US6764996 Bactericides for infections
07/15/2004WO2004058755A2 Compound libraries of imidazo[1,5-a]pyridin-3-yl derivatives and related heterobicycles for targetting compounds capable of binding to g-protein coupled receptors
07/15/2004WO2004058754A1 Benzoazolypiperazine derivatives having mglur1- and mglur5-antagonistic activity
07/15/2004WO2004058749A1 Benzisoxazole derivatives useful as inhibitors of protein kinases
07/15/2004WO2004058741A1 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
07/15/2004WO2004058733A1 Non-steroidal anti-inflammatory agents
07/15/2004WO2004058730A2 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
07/15/2004WO2004058729A1 New pyridazin-3(2h)-one derivatives
07/15/2004WO2004058722A1 Diarylamine and arylheteroarylamine pyrazole derivatives as modulators of 5ht2a
07/15/2004WO2004058720A2 Compound libraries of 1,3,5-substitute indazole derivatives as compounds for targetting compounds capable of binding to the g-protein coupled receptor
07/15/2004WO2004058716A1 Substituted 4-aryl pyridines used as kiss-1 antagonists
07/15/2004WO2004058709A1 Ccr8 inhibitors
07/15/2004WO2004058702A2 4-[(4-(carboxyethyl) piperidinyl) methyl] pyrrolidines as modulators of chemokine receptor activity
07/15/2004WO2004058265A1 Compound libraries of 2,3-substituted pyrazine derivatives capable of binding to g-protein coupled receptors
07/15/2004WO2004058264A1 Compound libraries of 2h-spiro (isoquinoline-1, -piperidine derivatives and related compounds for targetting compounds capable of binding to the g-protein receptor
07/15/2004WO2004058263A1 Compound libraries of 2, 3, 4, 9-tetrahydrospiro (beta-carboline-1, 4 -piperidine) derivatives and related compounds for targetting compounds capable of binding to the g-protein receptor
07/15/2004WO2004058259A1 Compound libraries of n-(aminocarbonyl)-piperidine-4-carboxamide derivatives capable of binding to g-protein coupled receptors
07/15/2004WO2004058149A2 1-(amino)indanes and (1,2-dihydro-3-amino)-benzofurans, benzothiophenes and indoles
07/15/2004WO2004052887A3 Substituted piperazine compounds and their use as fatty acid oxidation inhibitors
07/15/2004WO2004048345A3 2,5-diketopiperazines for the treatment of obesity
07/15/2004WO2004046122A3 Benzoxazole, benzthiazole and benzimidazole acid derivatives and their use as heparanase inhibitors
07/15/2004WO2004046092A3 Aryl sulfonamides
07/15/2004WO2004043366A3 Sulfonamides
07/15/2004WO2004041163A3 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity
07/15/2004WO2004032848A3 Pgd2 receptor antagonists for the treatment of inflammatory diseases
07/15/2004WO2004014881B1 '1,2,4'oxadiazoles as modulators of metabotropic glutamate receptor-5
07/15/2004WO2004006846A3 Receptor-type kinase modulators and methods of use
07/15/2004WO2004004714A1 Spirocyclic piperidines as mch1 antagonists and uses thereof
07/15/2004WO2003011853A8 6-aryl-4-aminopicolinates and their use as herbicides
07/15/2004US20040138464 Compounds as enzyme inhibitors, cosmetics, antitumor agents and food supplements
07/15/2004US20040138450 Agriculture salts and oxides
07/15/2004US20040138277 Syndrome X, hyperglycemia, hyperlipidemia, obesity, atherosclerosis; anticoagulant, hypotensive, and antidiabetic agents; cardiovascular disorders
07/15/2004US20040138262 Antiinflammatory agents; antiallergens; vision defects; anticancer agents; gastrointestinal disorders
07/15/2004US20040138230 Psychological and central nervous system disorders; alzheimer's disease; Huntington's disease
07/15/2004US20040138229 Platelet adenosine diphosphate receptor antagonists
07/15/2004US20040138227 Antiserotonine agents; antidepressants
07/15/2004US20040138220 Central nervous system disorder; gastrointestinal disorders; asthma; skin disorders; inflammatory bowel disorders; analgesics
07/15/2004US20040138219 Quinolines and nitrogenated derivative therof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents
07/15/2004US20040138213 Dihydronaphthalene derivative compounds and drugs containing these compounds as the active ingredient
07/15/2004US20040138205 Viricides; hepatitis virus
07/15/2004US20040138203 Antiserotonine agents
07/15/2004US20040138160 Administering tyrosine kinase inhibitor; suppression signal; blocking her gene
07/15/2004DE10300111A1 Verfahren zur Herstellung von Process for the preparation of 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
07/15/2004CA2512099A1 New pyridazin-3(2h)-one derivatives
07/15/2004CA2485375A1 Spirocyclic piperidines as mch1 antagonists and uses thereof
07/14/2004EP1437349A1 Substituted isoxazoles and the use thereof as antibiotics
07/14/2004EP1437346A1 Benzamide derivatives useful as cell differentiation inducers
07/14/2004EP1436287A2 Small organic molecule regulators of cell proliferation
07/14/2004EP1436269A1 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors
07/14/2004EP1435958A1 Use of phosphorodiesterase iv inhibitors
07/14/2004EP1435955A2 N-aroyl cyclic amine derivatives as orexin receptor antagonists
07/14/2004EP1435951A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the tretment of obesity
07/14/2004EP1435949A1 2' -methyl-5-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
07/14/2004EP1435948A1 Aminoisoxazole derivatives active as kinase inhibitors